Reliable Single Cell Cloning with Advanced Microfluidics Dispensing
Do you need a reliable, high-throughput method for selective single cell cloning?
Ensuring that biotherapeutics are derived from a single clonal source has been stipulated by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) in order to ensure consistency and quality of production and to reduce population heterogeneity. Aligned with these requirements, the Cyto-Mine® single cell analysis platform has been specifically designed to ensure monoclonality via accurate and reliable single cell dispensing.
To demonstrate the suitability of the Cyto-Mine® platform as a tool for cloning cells, we conducted a study to examine the fidelity of Cyto-Mine’s advanced microfluidic dispensing technology.
Learn how streamlined workflows using Cyto-Mine® technology offers:
Single cell visualization providing evidence of monoclonality to support regulatory requirements.
Very high dispensing fidelity observed at ≥ 98.9% accuracy.
Download the application note:
Sphere Bio Ltd will process your personal data in strict accordance with our privacy policy which can be found here. This will include sending you updates about Sphere Bio Ltd, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send.
The Next Generation: Cyto-Mine® Chroma
Automate. Accelerate. Analyze millions of cells in a single day.
Think Cyto-Mine®, but supercharged, enabling multiplexing and greater assay flexibility to fit your needs. It means that you can examine vastly greater numbers of cells — and isolate the most valuable ones— with unparalleled precision.
